At the beginning of 2017, the Trump Administration committed to reducing federal regulation and reining in regulatory costs. However, the SARS-CoV-2 coronavirus has infiltrated the legislative and regulatory world – just as it has every other facet of life.
COVID-19 Prompts Regulation Rollbacks, And 3 May Have Lasting Effects For Health Care
